152: Pharmacoeconomic Analysis of Therapeutic Regimens Used for Treatment of Psoriasis in India

Statement of Purpose, Innovation or Hypothesis: To perform cost-minimization analysis and cost-effective analysis of different therapeutic regimens prescribed to patients for pharmacoeconomic burden to the outdoor patient department of Dermatology KGMU, Lucknow.

Description of Methods & Materials: Pharmacoeconomic analysis of topicals regimens was assessed on the basis of data collection in the first visit and were monitored during follow up visits of patients, and assessments were done by the following parameter. Patients were divided into two topical groups, and analysis was done. Group A - Topical Corticosteroid; Group B - Topical corticosteroid + Salicylic acid.

Data & Results: The mean costing for Group-A was 2360.87 ± 801.24 and for Group-B was 6057.69 ± 2765.23. The overall cost-effective ratio was 5815.38. While analyzing the percent cost variations, the Topical corticosteroid + Salicylic acid (Group-B) combination showed the maximum variations (26.34) as compared to the medication of Topical corticosteroid (Group-A) only.

Interpretation, Conclusion or Significance: Group-B was approximately 2.6 times (Rs.) more expensive than Group-A and had Cost-Effective Ratio (CER) of 5815.38. Addition of salicylic acid showed speedy recovery at the initial phase only. However, the final outcomes were comparable in relation clobetasol alone. Moreover, salicylic acid was more expensive.

Disclosures: No conflict of Interest

Citations/References: Jolicoeur LM, Jones-Grizzle AJ, Boyer JG. Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm. 1992 Jul;49(7):1741-7. PMID: 1621734.

Additional Information/Authors: Dr. FARAH ASIF, Dr. SHOEBUL HAQUE, Prof. AMOD KUMAR, Prof. R. NATH, Dr. SWASTIKA, Dr. PARUL